MedTrace Logo

FIRST-Oslo Long-term Follow-up

NCT04870619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2023-11-03

No results posted yet for this study

Summary

The study aims to describe the functional level of the patients who received high intensity gait training during inpatient stroke rehabilitation at discharge, three, six and twelve months after stroke. These data will determine if the observed gains from the high-intensity gait training are retained after discharge from inpatient rehabilitation.

Conditions

Interventions

OTHER

High Intensity Gait Training

The intervention provided in this project is routinely delivered as a standard of care at the participating sites for patients after stroke that have a goal of walking improvement. The intervention consists of 45-60 minute, physical therapy sessions that occur five days per week (not weekends), focusing on prioritizing stepping practice at higher aerobic intensities during scheduled treatments (target training zone of 70-85% heart rate max (HRmax). Stepping is performed on treadmills and over ground, with safety harness systems and body weight support only as needed to ensure successful stepping. Tasks are progressed by increasing task difficulty as determined by the therapist. Accordingly, practice of non-walking tasks performed during physiotherapy, including bed mobility, transfers, and standing balance/ pre-gait activities, is limited.

Sponsors & Collaborators

  • Indiana University School of Medicine

    collaborator OTHER

  • Norwegian Fund for Postgraduate Training in Physiotherapy

    collaborator OTHER

  • City of Oslo

    collaborator UNKNOWN

  • Sunnaas Rehabilitation Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Elisabeth Bø, PhD · Oslo Univeristy Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-20
Primary Completion
2023-09-04
Completion
2023-09-04

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04870619 on ClinicalTrials.gov